Tool harnesses photo database to improve diagnostic accuracyIn the first major study to examine the use of a computer-assisted, photo-driven differential diagnosis generator for skin conditions...

Amgen has announced the initiation of a clinical trial, NCT02366195, to determine whether baseline CD8+ T lymphocytes density is a biomarker of response to talimogene laherparepvec, an...

Micreos, a Dutch biotech company, presented data on the potential use of endolysins as an alternative to antibiotics at the Royal Society of Medicine (RSM) Medical Innovations Spring Summit.

Complex wounds are a significant burden on patients and on the economyDeciding how to treat a complex wound is a bit like shopping at a supermarket: there's a lot to choose from.

Results of the St. Jude Children's Research Hospital-led study provide a target for developing novel therapies to tame the inflammation that drives autoinflammatory diseasesResearchers have...

Research from Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health shows more than a third of New Jersey high school students who engage in indoor tanning do so frequently and...

MSD (known as Merck & Co Inc. in the United States and Canada) has announced results from the randomised, pivotal Phase 3 study, KEYNOTE-006 which compared pembrolizumab to ipilimumab in patients...

Scientists from the Goethe University Frankfurt, the European Molecular Biology Laboratory Heidelberg and the University of Zurich explain skin fusion at a molecular level and pinpoint the specific...

Researchers have identified two drugs - an antifungal and a steroid - that reversed MS in mouse models of the condition by stimulating stem cells to boost myelin production.

Giving the two immunotherapies ipilimumab and nivolumab simultaneously yielded better treatment responses than ipilimumab alone in patients with advanced melanoma who received no prior treatment...